<table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col></col>
<col></col>
<col></col>
<col></col>
<tbody>
<tr>
<td> <content stylecode="bold">Coadministered drug</content>
</td>
<td> <content stylecode="bold">Dose schedules</content>
</td>
<td> </td>
<td> <content stylecode="bold">Effect on quetiapine pharmacokinetics</content>
</td>
</tr>
<tr>
<td> </td>
<td> <content stylecode="bold">Coadministered drug</content>
</td>
<td> <content stylecode="bold">Quetiapine</content>
</td>
<td> </td>
</tr>
<tr>
<td> Phenytoin</td>
<td> 100 mg threetimes daily</td>
<td> 250 mg threetimes daily</td>
<td> 5 fold Increase inoral clearance</td>
</tr>
<tr>
<td> Divalproex</td>
<td> 500 mg twicedaily</td>
<td> 150 mgtwice daily</td>
<td> 17% increase meanmax plasmaconcentration atsteady state.</td>
</tr>
<tr>
<td>  </td>
<td>  </td>
<td>  </td>
<td> No affect on absorption or mean oral clearance</td>
</tr>
<tr>
<td> Thioridazine </td>
<td> 200 mg twice daily </td>
<td> 300 mgtwice daily </td>
<td> 65% increase in oral clearance </td>
</tr>
<tr>
<td> Cimetidine </td>
<td> 400 mg three times daily for 4days</td>
<td> 150 mg three times daily </td>
<td> 20% decrease in mean oral clearance </td>
</tr>
<tr>
<td> Ketoconazole (potent CYP 3A4 inhibitor)</td>
<td> 200 mg once daily for 4 days</td>
<td> 25 mg single dose</td>
<td> 84% decrease in oral clearance resulting in a 6.2 fold increase in AUC of quetiapine </td>
</tr>
<tr>
<td> Fluoxetine </td>
<td> 60 mg once daily </td>
<td> 300 mg twice daily </td>
<td> No change in steady state PK </td>
</tr>
<tr>
<td> Imipramine</td>
<td> 75 mg twice daily </td>
<td> 300 mg twice daily </td>
<td> No change in steady state PK </td>
</tr>
<tr>
<td> Haloperidol</td>
<td> 7.5 mg twice daily </td>
<td> 300 mg twice daily </td>
<td> No change in steady state PK </td>
</tr>
<tr>
<td> Risperidone </td>
<td> 3 mg twice daily </td>
<td> 300 mg twice daily </td>
<td> No change in steady state PK </td>
</tr>
</tbody>
</table>